These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 28288000)
1. Age-associated chromatin relaxation is enhanced in Huntington's disease mice. Park M; Min B; Jeon K; Cho S; Park JS; Kim J; Jeon J; Song J; Kim S; Jeong S; Seo H; Kang YK Aging (Albany NY); 2017 Mar; 9(3):803-822. PubMed ID: 28288000 [TBL] [Abstract][Full Text] [Related]
2. The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington's Disease. Dong X; Tsuji J; Labadorf A; Roussos P; Chen JF; Myers RH; Akbarian S; Weng Z PLoS One; 2015; 10(12):e0144398. PubMed ID: 26636336 [TBL] [Abstract][Full Text] [Related]
3. Systematic genetic interaction studies identify histone demethylase Utx as potential target for ameliorating Huntington's disease. Song W; Zsindely N; Faragó A; Marsh JL; Bodai L Hum Mol Genet; 2018 Feb; 27(4):649-666. PubMed ID: 29281014 [TBL] [Abstract][Full Text] [Related]
4. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model. van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347 [TBL] [Abstract][Full Text] [Related]
6. PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically. Dickey AS; Pineda VV; Tsunemi T; Liu PP; Miranda HC; Gilmore-Hall SK; Lomas N; Sampat KR; Buttgereit A; Torres MJ; Flores AL; Arreola M; Arbez N; Akimov SS; Gaasterland T; Lazarowski ER; Ross CA; Yeo GW; Sopher BL; Magnuson GK; Pinkerton AB; Masliah E; La Spada AR Nat Med; 2016 Jan; 22(1):37-45. PubMed ID: 26642438 [TBL] [Abstract][Full Text] [Related]
7. Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington's disease. Lee J; Hwang YJ; Kim Y; Lee MY; Hyeon SJ; Lee S; Kim DH; Jang SJ; Im H; Min SJ; Choo H; Pae AN; Kim DJ; Cho KS; Kowall NW; Ryu H Acta Neuropathol; 2017 Nov; 134(5):729-748. PubMed ID: 28593442 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic and transcriptional modulation of WDR5, a chromatin remodeling protein, in Huntington's disease human induced pluripotent stem cell (hiPSC) model. Baronchelli S; La Spada A; Ntai A; Barbieri A; Conforti P; Jotti GS; Redaelli S; Bentivegna A; De Blasio P; Biunno I Mol Cell Neurosci; 2017 Jul; 82():46-57. PubMed ID: 28476540 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation profiling in human Huntington's disease brain. De Souza RA; Islam SA; McEwen LM; Mathelier A; Hill A; Mah SM; Wasserman WW; Kobor MS; Leavitt BR Hum Mol Genet; 2016 May; 25(10):2013-2030. PubMed ID: 26953320 [TBL] [Abstract][Full Text] [Related]
14. Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy. Chang R; Liu X; Li S; Li XJ Drug Des Devel Ther; 2015; 9():2179-88. PubMed ID: 25931812 [TBL] [Abstract][Full Text] [Related]
15. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Weydt P; Pineda VV; Torrence AE; Libby RT; Satterfield TF; Lazarowski ER; Gilbert ML; Morton GJ; Bammler TK; Strand AD; Cui L; Beyer RP; Easley CN; Smith AC; Krainc D; Luquet S; Sweet IR; Schwartz MW; La Spada AR Cell Metab; 2006 Nov; 4(5):349-62. PubMed ID: 17055784 [TBL] [Abstract][Full Text] [Related]
16. Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation. Biagioli M; Ferrari F; Mendenhall EM; Zhang Y; Erdin S; Vijayvargia R; Vallabh SM; Solomos N; Manavalan P; Ragavendran A; Ozsolak F; Lee JM; Talkowski ME; Gusella JF; Macdonald ME; Park PJ; Seong IS Hum Mol Genet; 2015 May; 24(9):2442-57. PubMed ID: 25574027 [TBL] [Abstract][Full Text] [Related]
17. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain. Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146 [TBL] [Abstract][Full Text] [Related]
18. Pathogenic Huntington Alters BMP Signaling and Synaptic Growth through Local Disruptions of Endosomal Compartments. Akbergenova Y; Littleton JT J Neurosci; 2017 Mar; 37(12):3425-3439. PubMed ID: 28235896 [TBL] [Abstract][Full Text] [Related]
19. Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes. Guiretti D; Sempere A; Lopez-Atalaya JP; Ferrer-Montiel A; Barco A; Valor LM Neurobiol Dis; 2016 May; 89():190-201. PubMed ID: 26851501 [TBL] [Abstract][Full Text] [Related]
20. Protection by dietary restriction in the YAC128 mouse model of Huntington's disease: Relation to genes regulating histone acetylation and HTT. Moreno CL; Ehrlich ME; Mobbs CV Neurobiol Dis; 2016 Jan; 85():25-34. PubMed ID: 26485309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]